 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/17/2018 |
$60.85 |
$61.50 |
$60.66 |
$61.30 |
4.43M | | 09/18/2018 |
$61.18 |
$61.66 |
$61.13 |
$61.48 |
3.70M | | 09/19/2018 |
$61.54 |
$62.24 |
$60.59 |
$60.80 |
4.45M | | 09/20/2018 |
$60.83 |
$61.95 |
$60.82 |
$61.75 |
4.52M | | 09/21/2018 |
$61.87 |
$62.62 |
$61.75 |
$62.25 |
9.01M |
|
|
| Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co. has products in the following therapeutic classes: oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus infection. Co.'s products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. Co. manufactures products in the U.S., Puerto Rico and in four foreign countries. Co.'s products include: Opdivo; Eliquis; Orencia; Sprycel; Yervoy; Empliciti; Baraclude; the Sustiva Franchise; the Reyataz Franchise; and Hepatitis C Franchise. | |
|
Bristol-Myers Squibb (BMY) has the following price history information. Looking back at BMY historical stock prices for the last five trading days, on September 17, 2018, BMY opened at $60.85, traded as high as $61.50 and as low as $60.66, and closed at $61.30. Trading volume was a total of 4.43M shares. On September 18, 2018, BMY opened at $61.18, traded as high as $61.66 and as low as $61.13, and closed at $61.48. Trading volume was a total of 3.70M shares. On September 19, 2018, BMY opened at $61.54, traded as high as $62.24 and as low as $60.59, and closed at $60.80. Trading volume was a total of 4.45M shares. On September 20, 2018, BMY opened at $60.83, traded as high as $61.95 and as low as $60.82, and closed at $61.75. Trading volume was a total of 4.52M shares. On September 21, 2018, BMY opened at $61.87, traded as high as $62.62 and as low as $61.75, and closed at $62.25. Trading volume was a total of 9.01M shares.
BMY Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Bristol-Myers Squibb shares, starting with a $10,000 purchase of BMY, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
| Start date: |
09/22/2008 |
|
| End date: |
09/21/2018 |
|
| Start price/share: |
$20.62 |
|
| End price/share: |
$62.25 |
|
| Starting shares: |
484.97 |
|
| Ending shares: |
697.11 |
|
| Dividends reinvested/share: |
$14.11 |
|
| Total return: |
333.95% |
|
| Average Annual Total Return: |
15.80% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$43,377.06 |
|
| Years: |
10.00 |
|
| |
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/22/2008 |
|
| End date: |
09/21/2018 |
|
| Start price/share: |
$20.62 |
|
| End price/share: |
$62.25 |
|
| Dividends collected/share: |
$14.11 |
|
| Total return: |
270.32% |
|
| Average Annual Total Return: |
13.98% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$37,020.49 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 09/17/2018 | $61.30 | | 09/18/2018 | $61.48 | | 09/19/2018 | $60.80 | | 09/20/2018 | $61.75 | | 09/21/2018 | $62.25 |
|
|
